Recent headlines around proposed US tariffs on European countries highlight just how volatile the global trade environment remains. As reported this week  in Fierce Pharma , potential new duties on several European nations raised questions about the future of US–EU trade relations and potential impacts on pharmaceuticals. For sponsors running global clinical trials, this kind of uncertainty can translate into real operational risk: fluctuating costs, sourcing delays, and regu

Client:  Mid-size biotech conducting multiple clinical trials Challenge: The client required a large quantity of Humira (adalimumab) for several upcoming studies. High costs and limited availability were putting pressure on study budgets and timelines. Solution: CSI leveraged its industry insight and direct relationships with the manufacturer to provide access to a high-quality adalimumab biosimilar. This saved the client a staggering 50% on price . By carefully coordinating

CSI's Managing Director, Vanessa Dekou PhD, MBA, hosted an inspiring talk at Imperial College London 's Entrepreneurship course, sharing the story behind the creation of Clinical Services International. By identifying a clear gap in the clinical supply market, Vanessa built CSI with a vision to deliver smarter, more agile solutions for global clinical trials. The session was highly engaging and extremely well received, sparking curiosity and ambition among the next generation

On the 12th day of Christmas CSI gave to me…   Twelve reasons sponsors trust CSI, all year long! On the 1st day of Christmas CSI gave to me…  Direct Manufacturer Access! Receive faster timelines and documentation thanks to CSI’s direct accounts with global pharma leaders. Reach out to CSI for a sourcing consultation, no matter how big or small your request. On the 2nd day of Christmas CSI gave to me… Unmatched sustainability; with an EcoVadis Platinum rating, putting us in t

As we prepare for Q1 2026, sponsors and CROs face a shifting global landscape for clinical trial comparator sourcing that focuses on sustainability, diversity and fair pricing. With our EcoVadis Platinum certification, women-owned business status and full scientific team in place, CSI is well placed to support our partner’s supply chains. 1. Supply-chain volatility is real Clinical supplies are increasingly challenged by geo-political pressures, export controls, and manufactu

By Clinical Services International As a proud Women-Owned Business , Clinical Services International (CSI)  is committed to transforming the global clinical supply landscape while championing gender equity and social responsibility. Founded on the principles of scientific excellence, ethical sourcing and diversity, CSI  stands at the forefront of pharmaceutical procurement and supply solutions for clinical trials worldwide. Women-owned businesses are vital to the global econo

As part of our ongoing commitment to excellence and continuous improvement, CSI is proud to announce the digitalization of our Quality Management System (QMS) through Simploud , a leading eQMS platform.   This transition marks an important milestone in enhancing both our customer and supplier experience, ensuring greater efficiency, transparency and compliance across our global operations.   Simploud ’s unified platform will streamline key quality processes (including CAPA ma

October is Breast Cancer Awareness Month and  Clinical Services International (CSI)  is wearing pink to show our solidarity with the cause. Pink is the colour of the ribbon that represents breast cancer awareness. Wearing pink on this day is a way to express support for breast cancer survivors, remember those lost to the disease and advocate for the progress in the fight against breast cancer. Reach out to CSI for your Breast Cancer studies, let's beat Breast Cancer together.

Client Overview A global biopharmaceutical company approached CSI to support a Phase III oncology study requiring Opdivo (nivolumab) as a comparator. The study spanned 4 countries across North America, Europe and Asia-Pacific, with a target enrolment of over 500 patients. The client’s main objective was to ensure timely delivery of branded Opdivo for multiple trial sites while maintaining transparent, full chain of custody and documentation.   Challenge There were several key

At CSI, we’ve built our reputation on being a trusted partner in advancing global health. Among our proudest achievements is our role in...